MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 29, 2003--VIVUS, Inc. (Nasdaq:VVUS) today announced that the Swedish Pharmaceutical Benefits Board has approved the reimbursement of transurethral therapy ...

Correction to: International Journal of Impotence Research (2005) 17, 86–90. doi:10.1038/sj.ijir.3901284; published online 4 November 2004 (http://www.nature.com ...

Oct. 21, 2005 (Montreal) — Early penile rehabilitation, particularly use of intraurethral alprostadil (MUSE), can help maintain healthy penile tissue after radical prostatectomy, allowing for improved ...

Erectile dysfunction (ED) impacts an estimated 18 million men in the U.S. alone, yet it is rarely discussed openly. John Smith, DO, a urologist at University of Utah Health, addresses the barriers to ...

Today, there are more treatments than ever. By David Dodge Erectile dysfunction is more common than one might think. More than half of men over 40 will experience some kind of erectile problem, and ...

MOUNTAIN VIEW, Calif. - Apr 4, 2008 - VIVUS, Inc. (NASDAQ: VVUS) announced today that it has entered into a $30 million funding collaboration with Deerfield Management ("Deerfield"). Under the terms ...

Erectile dysfunction (ED) is when you have trouble achieving or keeping an erection. ED can also be an early sign of an underlying health condition. ED causes significant stress, anxiety, or ...